retatrutide mechanism triple agonist glp-1 gip glucagon Spatiotemporal and receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists Weight Reduction with GLP-1 Medication:Tirzepatide (GLP-1 + GIP) Heart & Vessels

retatrutide mechanism triple agonist glp-1 gip glucagon Spatiotemporal and receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists Weight Reduction with GLP-1 Medication:Tirzepatide (GLP-1 + GIP) Heart & Vessels

Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss

For example, some medications are given once daily, while others are administered once a week

Heart & Vessels

Medication:Tirzepatide (GLP-1 + GIP)

If the concentration is 1 mg/mL, that same 0.05 mL contains only 0.05 mg, and you'd need 0.50 mL (50 units) to get 0.5 mg